Jinpeng Liu Selected Research

Metabolic Diseases (Metabolic Disease)

11/2022	Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers.
1/2021	Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinpeng Liu Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 01/2017
5	Fibrosis (Cirrhosis) 01/2024 - 10/2022
5	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2019
5	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 01/2018
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Inflammation (Inflammations) 01/2024 - 01/2020
3	Myopia 12/2023 - 10/2022
3	Adenocarcinoma of Lung 09/2023 - 09/2020
3	Melanoma (Melanoma, Malignant) 02/2023 - 01/2018
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
2	Obesity 02/2024 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 06/2023
2	Metabolic Diseases (Metabolic Disease) 11/2022 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 10/2022 - 01/2021
2	Solitary Kidney 01/2019 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 05/2018
1	Atherosclerotic Plaque (Atheroma) 02/2024
1	Atherosclerosis 02/2024
1	Liver Diseases (Liver Disease) 01/2024
1	Pericardial Effusion 01/2024
1	Pneumonia (Pneumonitis) 10/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2023
1	Triple Negative Breast Neoplasms 05/2023
1	Acute Coronary Syndrome 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Hemorrhage 01/2023

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2018
6	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
4	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2018
3	MethyltransferasesIBA 01/2024 - 01/2022
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 05/2018
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 06/2022 - 05/2018
3	ErbB Receptors (EGF Receptor)IBA 11/2021 - 01/2017
2	NeurotensinIBA 02/2024 - 01/2020
2	BerberineIBA 01/2024 - 01/2021
2	Bile Acids and Salts (Bile Acids)IBA 01/2024 - 10/2022
2	InterferonsIBA 01/2024 - 06/2023
2	Messenger RNA (mRNA)IBA 01/2024 - 06/2023
2	B7-H1 AntigenIBA 01/2024 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2019
2	Polycomb Repressive Complex 2IBA 10/2023 - 01/2023
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2023 - 10/2020
2	Retinaldehyde (Retinal)IBA 01/2023 - 10/2020
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2023 - 01/2023
2	CollagenIBA 01/2023 - 01/2023
2	LipidsIBA 10/2022 - 05/2018
2	Long Noncoding RNAIBA 10/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 11/2021 - 01/2021
2	Hormones (Hormone)IBA 12/2020 - 01/2020
2	CreatinineIBA 10/2020 - 10/2020
2	CateninsIBA 12/2019 - 01/2018
2	TVB-3664IBA 01/2019 - 05/2018
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2018
1	Triglycerides (Triacylglycerol)IBA 02/2024
1	oil red OIBA 02/2024
1	Peptide Hormones (Polypeptide Hormones)IBA 02/2024
1	CholesterolIBA 02/2024
1	AlkaloidsIBA 01/2024
1	isoquinolineIBA 01/2024
1	Keratins (Keratin)IBA 01/2024
1	Uric Acid (Urate)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	Carcinoembryonic AntigenIBA 01/2024
1	big gastrinIBA 01/2024
1	AntigensIBA 01/2024
1	pro-gastrin-releasing peptide (31-98)IBA 01/2024
1	squamous cell carcinoma-related antigenIBA 01/2024
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2023
1	Phosphates (Orthophosphate)IBA 12/2023
1	SolventsIBA 12/2023
1	Acetates (Acetic Acid Esters)FDA Link 12/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2023
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 12/2023
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 11/2023
1	OvalbuminIBA 10/2023
1	Polo-Like Kinase 1IBA 09/2023
1	Chemotactic FactorsIBA 05/2023
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2023
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2023
1	Histone MethyltransferasesIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	iodohydroxybenzylpindololIBA 01/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2022

Therapy/Procedure

10	Therapeutics 01/2024 - 01/2020
5	Immunotherapy 01/2024 - 10/2020
4	Transplantation 10/2020 - 04/2016
2	Percutaneous Coronary Intervention 01/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
2	Precision Medicine 11/2021 - 05/2018
1	Intravitreal Injections 12/2023
1	Stents 01/2023